Understanding and improving healthy aging for World Trade Center responders
Promoting healthy aging among WTC responders: Frailty trajectories and intervention strategies
This study is looking at the health of World Trade Center responders as they age, especially to see who might be at risk for becoming frail, and it aims to find ways to help improve their quality of life.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10848178 on NIH RePORTER |
What this research studies
This research focuses on the aging of World Trade Center (WTC) responders, particularly those who are now at risk for frailty and other aging-related conditions. The team has developed a specific frailty assessment tool to evaluate the health of these responders, aiming to identify those at higher risk for adverse health outcomes. By systematically assessing frailty and its consequences, the research seeks to implement intervention strategies that can enhance the quality of life for these aging individuals. The study will involve collecting data on physical measures and functional impairments to better understand the needs of this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are World Trade Center responders aged 65 and over who may be experiencing signs of frailty.
Not a fit: Patients who are not WTC responders or those who are younger than 65 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and quality of life for aging WTC responders.
How similar studies have performed: Similar research has shown success in assessing frailty in aging populations, indicating that this approach could be beneficial for WTC responders as well.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Ko, Fred Chau-Yang — Icahn School of Medicine at Mount Sinai
- Study coordinator: Ko, Fred Chau-Yang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.